Achondroplasia
from OrphaChat — a Rare Disease Podcast Hosted by RCH
These sources provide a comprehensive overview of achondroplasia, the most prevalent genetic cause of disproportionate short stature, primarily driven by FGFR3 gene mutations. The documentation details critical medical complications across the lifespan, including spinal stenosis, sleep apnea, and hearing loss, while emphasizing the necessity of multidisciplinary clinical surveillance. Current and emerging pharmacological treatments, such as vosoritide and infigratinib, are highlighted for their potential to modify bone growth and improve patient outcomes. Beyond clinical data, the texts explore the socioeconomic and psychological impacts on patients and their families, noting challenges in daily functioning and quality of life. Research also examines epidemiological trends and the biological link between advanced paternal age and the occurrence of these genetic variants. Together, these materials underscore a shift toward standardised global care and innovative precision therapies to manage the condition’s complex symptoms.
Embed this episode
No transcript yet.